Ruzurgi (amifampridine)

pCPA File Number: 21457

Negotiation Status:

Concluded without agreement

Indication(s):

Lambert-Eaton Myasthenic Syndrome (LEMS)

Sponsor/Manufacturer:

Médunik Canada Inc.

CDA-AMC Project Number:

SR0660-000

pCPA Engagement Letter Issued:

2021-10-18

Negotiation Process Concluded:

2022-06-01